During the COVID-19 pandemic, the demand for N95 respirators is surging. The Battelle CCDS Critical Care Decontamination SystemTM was developed and implemented to enhance continued preservation efforts of critical personal protective equipment, while ensuring the safety of front-line workers. In order to utilize the CCDS service, hospitals and health systems have implemented new processes to collect and redistribute decontaminated respirators to their teams.
What’s the optimal way to add a new process into your supply chain operations and make it safe and efficient?
Join us for an engaging discussion with the Battelle CCDSTM team, Mass General Brigham and University Pittsburgh Medical Center (UPMC) as each hospital discusses their unique strategy for collecting and redistributing decontaminated respirators, and how they increased utilization of the CCDS system.
- Details about the Battelle CCDSTM decontamination process;
- How to ensure a high return rate for your decontaminated respirators;
- How to index for dedicated-end users vs. general reuse
- Best practice strategies and tactics to use in your hospital.
Mass General Brigham
- Phil Licari, Vice President of Operations & Innovation
- Danielle Le Hals, Executive Director, Radiation Oncology
- Bart Wyss, Senior Director Logistics, Distribution & Transportation
- Joe Berger, Vice President of Sales and Marketing
- Kevin Sayers, Senior. Regulatory Specialist
- Doug Shaw, Senior Vice President of Field Engagement
The Food & Drug Administration June 7 reissued an emergency use authorization stating health care personnel should use the decontamination process only when new, FDA-cleared N95 respirators, NIOSH-approved N95 respirators, or other FDA-authorized respirators are not available. Learn more here.